VedaBio
CRISPR powered Diagnostics with results in minutes.
About VedaBio
Where is VedaBio headquartered?
VedaBio is headquartered in San Diego, CA.
What does VedaBio do?
CRISPR powered Diagnostics with results in minutes.
What problem does VedaBio solve?
Existing molecular detection methods like PCR require target amplification, which limits detection speed and how many targets can be tested (multiplexed) at once.
What's VedaBio's solution?
VedaBio's 'CRISPR Cascade' platform uses engineered CRISPR enzymes to detect a molecular target and amplify the resulting signal directly, delivering results without needing target amplification.
What makes VedaBio different?
The company states its Cascade technology achieves results in minutes, supports massive multiplexing of pooled targets (unlike PCR or other amplification technologies), and can be rapidly reprogrammed for new targets through simple sequence selection.
What makes VedaBio notable?
VedaBio, founded by CEO Anurup Ganguli, launched from stealth with over $40 million led by OMX Ventures and has since licensed CRISPR technology from Mammoth Biosciences.
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.